Belly fat in perimenopause and menopause is not a consequence of eating more or moving less. It is a direct result of the hormonal changes that accompany the end of reproductive life, specifically the decline in oestrogen, which changes where the body preferentially stores fat. The shift is from the hips and thighs toward the abdomen, and the fat that accumulates there is metabolically active in ways that carry real health implications. Understanding this helps explain why the same diet and exercise that worked before menopause may feel like it is no longer working, and why managing it well requires more than simply trying harder.
The Conversation I Have More Than Almost Any Other
A version of this comes up in my clinic regularly. A woman in her late forties or early fifties, often someone who has managed her weight reasonably well for most of her adult life, describes a change that feels sudden and confusing. She has not changed what she eats. She is still moving. But her abdomen has changed, and the strategies that used to work are no longer producing the same results. Sometimes she has already been told that she just needs to eat less. Sometimes she has been told it is a normal part of ageing and there is not much to be done.
Both of those responses, while well-intentioned, miss what is actually happening biologically. And when the biology is not explained, women tend to fill the gap with self-blame. That is a pattern I find clinically unhelpful and personally frustrating, because the explanation is available and it is worth knowing.
What Oestrogen Has Been Doing All Along
Throughout the reproductive years, oestrogen plays a significant role in regulating where fat is stored in the body. It’s influence is one of the reasons that women and men tend to carry fat differently. Under the influence of oestrogen, the body preferentially deposits subcutaneous fat in the hips, thighs, and gluteal region. This is sometimes called the gynoid fat distribution pattern, and while it may not always be welcome aesthetically, it is metabolically relatively benign. Subcutaneous fat in the lower body is less inflammatory, less metabolically active, and carries lower cardiometabolic risk than fat stored in the abdomen.
When oestrogen declines during perimenopause and menopause, this regulatory influence is lost. The body shifts from a gynoid to an android pattern of fat distribution, the same pattern more commonly seen in men. Fat begins to accumulate preferentially in the abdominal region, and specifically in the visceral compartment: the fat stored deep within the abdomen, around the internal organs.
A longitudinal study tracking women across the menopausal transition found that visceral fat increased significantly in the years surrounding menopause onset, and that this increase occurred in parallel with falling oestradiol levels, not simply with age (Lovejoy et al., 2008). The same study also found that sleeping energy expenditure declined more steeply in women who transitioned to menopause than in those who remained premenopausal, suggesting that metabolic rate is itself affected by the hormonal shift. This matters because it means the caloric equation changes at menopause even without any change in behaviour.
Why Visceral Fat Is Clinically Different
Not all fat carries the same health implications, and this distinction is worth understanding in some detail. Subcutaneous fat, the kind you can pinch, sits beneath the skin and is metabolically relatively quiet. Visceral fat, by contrast, sits inside the abdominal cavity, surrounding the liver, pancreas, and intestines. It is biologically active in a way that subcutaneous fat is not: it releases inflammatory molecules and free fatty acids directly into the circulation, contributing to insulin resistance, elevated triglycerides, and increased cardiovascular risk.
The shift toward visceral fat accumulation that occurs with the menopause transition is therefore not purely a cosmetic matter. It represents a genuine change in metabolic risk profile. Research indicates that visceral fat constitutes around five to eight per cent of total body fat in premenopausal women. After menopause, that proportion can increase to fifteen to twenty per cent (Vecchiatto et al., 2025). That is a meaningful shift, and it occurs largely independently of changes in overall weight. A woman can maintain the same weight across the menopausal transition while her body composition changes considerably underneath it.
This is one of the reasons I place significant value on body composition monitoring in our patients at Alevia, particularly those navigating perimenopause and menopause. The scale tells you one number. Body composition assessment tells you a more complete story, and in this stage of life, the more complete story is often the more clinically important one.
Why The Diet That Worked Before May Not Work The Same Way Now
This is the part that tends to resonate most strongly with women who arrive in the clinic having already tried. The strategies that produced results in their thirties or early forties, a period of modest caloric reduction, slightly more exercise, a few weeks of consistent effort, can feel as though they have simply stopped working. The biology behind this is real.
The metabolic rate change associated with menopause means that energy requirements are genuinely lower than they were. What was a slight deficit before is now maintenance, or close to it. At the same time, the hormonal environment becomes less supportive of muscle preservation. Oestrogen has an anabolic role in skeletal muscle: it supports muscle protein synthesis and limits breakdown. As it declines, the body becomes less efficient at turning dietary protein into muscle mass. This is sometimes described as anabolic resistance, and it is not reversible through effort alone.
The practical consequence is that a diet that was adequate for maintaining muscle mass in a premenopausal woman may be insufficient in a postmenopausal one. Research in the area of protein leverage suggests that the body has a stronger appetite signal for protein than for other macronutrients, and that if protein needs are not met, total energy intake tends to increase to compensate (Simpson et al., 2023). In other words, inadequate protein intake in menopause may actually drive increased overall food consumption rather than reducing it.
Muscle Mass Loss in Women: Pre vs Post Menopause
Premenopausal (roughly age 30–50)
Women lose approximately 3–8% of muscle mass per decade from around age 30 onwards, consistent with the general adult population.
The rate is relatively gradual and often partially offset by physical activity and adequate nutrition.
Oestrogen plays a protective role in muscle protein synthesis and satellite cell activation during this period
Perimenopausal transition
The transition period (typically 2–3 years around the final menstrual period) is associated with an accelerated loss, estimated at up to 1–2% per year during this window.
Falling oestrogen levels reduce anabolic signalling, increase inflammatory cytokines, and impair insulin sensitivity — all of which accelerate muscle catabolism.
Postmenopausal
After menopause, the rate increases to approximately 5–10% per decade (some studies cite even higher in sedentary women).
The first 5–10 years post-menopause appear to be the most critical window of accelerated loss.
Fat mass tends to increase simultaneously, meaning body weight may be stable even as body composition deteriorates significantly — making DEXA/body composition monitoring particularly important in this group.
I recommend adequate protein intake as a clinical priority in this stage of life. The evidence points toward a range of 1.2 to 1.6 grams per kilogram of body weight per day for women in perimenopause and beyond, which is meaningfully above the standard dietary guidelines designed for the general adult population. This is not about high-protein dieting in the popular sense. It is about meeting the specific physiological needs of a body that is processing protein less efficiently than it used to.
The Role Of Muscle, And Why Cardio Alone Is Not The Full Answer
Muscle loss in menopause is closely tied to the visceral fat story because muscle mass and metabolic rate are directly connected. The more lean muscle tissue a person carries, the higher their resting energy expenditure. As muscle declines, metabolic rate declines with it. This creates a compounding effect: the hormonal environment of menopause both promotes visceral fat accumulation and makes muscle maintenance harder, while losing muscle further reduces the metabolic rate and makes managing weight more difficult.
Aerobic exercise remains valuable in menopause for cardiovascular health, mood, sleep, and overall metabolic function. But aerobic exercise alone does relatively little to preserve or build muscle mass. Resistance training, the kind that challenges muscle directly through load, is the intervention with the strongest evidence for preserving lean mass in postmenopausal women. Two or more sessions per week, progressively loaded over time, provide the stimulus that the muscle needs to adapt and maintain itself in the absence of the hormonal support that oestrogen previously provided.
The combination of adequate protein and progressive resistance training is more effective than either alone. This is not a surprising finding, but it is an important one, because many women in this stage of life are doing significant amounts of cardio and wondering why their body composition is not changing in the way they hope.
What This Means For Managing It
Managing belly fat in menopause is not about restriction. It is about understanding the changed biological environment and responding to it appropriately. That response involves several things working together.
Protein intake needs to be actively assessed rather than assumed. Most women are eating considerably less protein than what the evidence supports for muscle preservation in this stage of life. A dietitian who specifically understands the menopausal context is valuable here, not generic healthy eating advice.
Resistance exercise needs to be part of the picture, consistently and progressively. This is a clinical recommendation, not an aesthetic one. Building and maintaining muscle in menopause has implications for metabolic health, bone density, falls risk, and long-term independence.
Sleep deserves clinical attention. Sleep disruption is extremely common in perimenopause and menopause, and it has direct effects on the hormones that regulate appetite and fat storage. Poor sleep increases ghrelin, decreases leptin, and elevates cortisol, all of which drive both food intake and abdominal fat accumulation. Treating sleep disruption is not peripheral to managing body composition in menopause. It is central to it.
Body composition monitoring, rather than scale weight alone, gives a more meaningful picture of what is actually changing. Visceral fat trends, lean mass changes, and fat distribution over time are far more clinically informative in this context than a weekly weigh-in.
And professional support that understands the specific hormonal and metabolic changes of menopause, rather than applying generic weight management frameworks that were not designed for this stage of life, tends to produce considerably better results.
Looking Forward
The women who struggle most with belly fat in menopause have usually not been given a good explanation of what is actually happening. They have been given advice calibrated for a body in a different hormonal environment, and when that advice fails, they have tended to attribute the failure to themselves.
The biology is not working against you. It is changing, and it requires a response that accounts for that change rather than ignoring it. The conversations I find most productive in the clinic are the ones where a patient understands the mechanism, because understanding the mechanism changes the frame from personal failing to clinical problem, and clinical problems have clinical responses.
If you are navigating perimenopause or menopause and finding that your body is not responding the way it used to, I would encourage you to bring that to a clinical conversation that takes the full hormonal picture into account. That is what we do at Alevia.
This article is general information and not personal medical advice. Treatment decisions should be made in consultation with a qualified health professional. Individual suitability varies and requires clinical assessment.
